Chiron operates a multi-condition AI platform designed to extend care beyond episodic clinic visits by creating continuous feedback loops between patients and providers. The company is expanding its platform into cardiometabolic health, gastrointestinal disorders, and women’s health. Chiron emphasizes an intelligent, integrated self-management layer that complements clinician care. The team is led by co-founder and CEO Carron Manning. Financially, the company recently raised a £900K seed round led by THENA Capital with participation from Arāya Ventures. The article does not disclose revenue, users, or prior funding rounds.

Total raised

$1M

Funding rounds

1

Latest round

Seed

Latest activity

Jul 2026